Curtis Head
Keine laufenden Positionen mehr
Profil
Curtis Head worked as a Principal at The University of California, San Francisco.
He also worked as Vice President-Clinical Operations at Relevare Aust Pty Ltd.
and Relevare Pharmaceuticals Ltd.
Mr. Head completed his undergraduate degree from San Francisco State University.
Ehemalige bekannte Positionen von Curtis Head
| Unternehmen | Position | Ende |
|---|---|---|
Relevare Pharmaceuticals Ltd.
 Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Technik-/Wissenschafts-/F&E-Leiter | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Relevare Aust Pty Ltd.
 Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia. | Corporate Officer/Principal | - |
Ausbildung von Curtis Head
| San Francisco State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Relevare Aust Pty Ltd.
Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia. | Health Technology |
Relevare Pharmaceuticals Ltd.
Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Health Technology |
